Condition: Epilepsy · Sponsor: Sahlgrenska University Hospital
PREDICT is an observational study following adults with an unprovoked seizure or epilepsy in the health care region of western Sweden. The objective is to identify biomarkers and/or genetic predisposition of relevance for diagnosis and/or treatment of epilepsy and study the long-term prognosis and consequences of epilepsy.
This description comes directly from the study's public registry record.
Johan Zelano, MD PhD · +46313421000 · johan.zelano@vgregion.se
Always discuss trial participation with your own doctor first.
| Södra Älvsborgs Sjukhus | Borås, Sweden | Recruiting |
| Sahlgrenska University Hospital | Gothenburg, Sweden | Recruiting |
| Sjukhusen i Väster | Gothenburg, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04559919